An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors
Clinical trial NCT02303444 · COMPLETED
Trial details
- NCT number
- NCT02303444
- Sponsor
- Bayer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2015-04-08
- Primary completion
- 2020-06-10
- Enrollment
- 667
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.